CASA and Ca 125 in diagnosis and follow-up of advanced ovarian cancer

Anticancer Research

Volumn 19, Issue 4 A, 1999, Pages 2513-2518

  Oehler, M K ^a,b,c   Sutterlin M ^a   Caffier, H ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

CA125; CASA; Diagnosis; Ovarian cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CA 125 ANTIGEN; TUMOR ANTIGEN;

ADVANCED CANCER; BLOOD LEVEL; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS;

ANTIGENS, NEOPLASM; BACTERIAL PROTEINS; CA-125 ANTIGEN; CELLULASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0344931704     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (16)

1. Mackey SE, Creasman WT: Ovarian cancer screening. J Clin Oncol 13: 783-793, 1995.
2. Potter ME, Hatch KD, Soong S, Partridge EE, Austin JM, Shingleton HM: Second look laparotomy and salvage therapy: A research modality only ? Gynecol Oncol 44: 3-9, 1992.
3. Bast RC, Feeney M, Lazarus H, Nadler LM, Colvin RB, Knapp RC: Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 68: 1331-1337, 1981.
4. Jacobs I, Bast RC: The CA 125 tumor associated antigen: a review of the literature. Human Reprod 4: 1-12, 1989.
5. Kabawat SE, Bast RC, Welch WR, Knapp RC, Colvin RB: Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometroid and clear cell types. Amer J Clin Pathol 79: 98-104, 1983.
6. Cordon Cardo C, Mattes MJ, Melamed MR, Lewis JL, Old LJ, Lloyd KO: Immunopathologic analysis of a panel of mouse monoclonal antibodies reacting with human ovarina carcinomas and other human tumors. Int J Gynecol Pathol 4:121-130, 1985.
7. Kaesemann H, Caffier H, Hoffmann FJ, Crombach G, Wurz H, Kreienberg R, Mobus V, Schmidt-Rhode P, Sturm G: Monoclonal antibodies in the diagnosis and follow-up of ovarian cancer. CA 125 as a tumor marker. A cooperative study of the Gynecologic Tumor Marker Group. Klin Wochschr 64: 781-785, 1986.
8. Mogensen O, Mogensen B, Jakobsen A, Sell A: Measurement of the ovarian cancer-associated antigen CA 125 prior to second look operation. Eur J Cancer Clin Oncol 24:1835-1837, 1988.
9. McGuckin MA, Layton GT, Bailey MJ, Hurst T, Khoo SK, Ward BG: Evaluation of two new assays for tumor associated antigens, CASA and OSA, found in serum of patients with epithelial ovarian carcinoma: comparison with CA 125. Gynecol Oncol 37: 165-171, 1990.
10. Slomiany BL, Slomiany A: Role of mucus in gastric mucosal protection. J Physiol Pharmacol 42: 147-161, 1991.
11. Zotter S, Hageman PC, Lossnitzer A: Tissue and tumor distribution of human polymorphic epithelial mucin. Cancer Rev 11-12: 55-101, 1988.
12. Layton GT, Xing PX, McKenzie IFC: Cancer-associated serum antigen (CASA) and ovarian serum antigen (OSA): two new serum tumor marker kits for detecting carcinoma-associated mucins. J Tumor Marker Oncol 6: 9-17, 1991.
13. Devine PL, Warren JA, Ward BG, McKenzie IFC, Layton GT: Glycosylation and the exposure of tumor-associated epitopes on mucins. J Tumor Marker Oncol 5: 11-26, 1990.
14. Kotera Y, Fontenot JD, Pecher G, Metzgar R S, Finn OJ: Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients. Cancer Res 54: 2856-2860, 1994.
15. Van der Zee AG, Duk JM, Aalders AB, Boontje AH, ten Hoor KA, de Bruijn HW: The effect of abdominal surgery on the serum concentration of the tumor-associated antigen CA 125. Brit J Obstet Gynaecol 97: 934-938, 1990.
16. McGuckin MA, Devine PL: The mucin marker,CASA, in ovarian cancer. Tumordiagn u Ther 16: 1-6, 1995.